Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Korro Bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 71 | +8 |
| Shares | 8.44M | 406.4K | 8.54M | +507.5K (+6.3%) |
| Value | $285.7M | $13.8M | $285.3M | +$13.3M (+4.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Korro Bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 449,950 | $15.0M | 0.00% |
| Siren, L.L.C. | 418,833 | $14.0M | 0.70% |
| Hudson Bay Capital Management LP | 30,000 | $1.00M | 0.01% |
| Wellington Management Group LLP | 13,052 | $436.2K | 0.00% |
| Blair William & Co | 12,200 | $407.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,350 | $112.0K | 0.00% |
| Deutsche Bank AG | 3,175 | $106.1K | 0.00% |
| Vestcor Inc | 3,000 | $100.0K | 0.00% |
| Jaffetilchin Investment Partners, LLC | 945 | $31.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 434 | $14.5K | 0.00% |
| Lindbrook Capital, LLC | 45 | $1.50K | 0.00% |
| Signaturefd, LLC | 41 | $1.37K | 0.00% |
| Nisa Investment Advisors, LLC | 22 | $735 | 0.00% |
| Sterling Capital Management LLC | 16 | $535 | 0.00% |
| GAMMA Investing LLC | 4 | $134 | 0.00% |
| CWM, LLC | 3 | $0 | 0.00% |
Sold out (8)
Institutions that held Korro Bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 413,072 | $14.0M |
| Walleye Capital LLC | 29,534 | $1.00M |
| Marshall Wace, LLP | 9,103 | $308.3K |
| Two Sigma Investments, LP | 6,355 | $215.2K |
| Qube Research & Technologies Ltd | 5,750 | $194.8K |
| Lynx1 Capital Management LP | 3,800 | $128.7K |
| Strategic Investment Solutions, Inc. | 10 | $95 |
| Kelly Financial Services LLC | 1 | $34 |
Not filed for Q3 2024 yet (1)
Institutions that held Korro Bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 406,381 | $13.8M |